SCHEMBL8287115

SCHEMBL8287115

Cc1cc(NCCO)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.44
RECQL P46063 1/20 0.39
MCL1 Q07820 1/20 0.39
GAA P10253 5/20 0.37
TSHR P16473 1/20 0.37
POLB P06746 3/20 0.37
IKBKB O14920 1/20 0.37
SLC2A1 P11166 1/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
PGK1 P00558 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
EGFR P00533 1/20 0.35
MAPK1 P28482 3/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287137 0.88 PDE11A (0.44) PDE11AGAATSHRPOLBHTT
SCHEMBL5871799 0.87 PDE11A (0.50) PDE11AGAATSHRPOLBHTT
SCHEMBL8287908 0.86 PDE11A (0.45) PDE11ARECQLSLC2A1HTTSMN1; SMN2
SCHEMBL8362727 0.86 PDE11A (0.46) PDE11AGAAIKBKBKMT2AHPGD
SCHEMBL8286369 0.86 PDE11A (0.59) PDE11ARECQLMCL1GAATSHR
SCHEMBL5871404 0.84 PDE11A (0.44) PDE11AGAATSHRPOLBSLC2A1
SCHEMBL5871689 0.84 PDE11A (0.46) PDE11AGAATSHRPOLBHTT
SCHEMBL8286057 0.83 KDM4E (0.44) PDE11ARECQLGAATSHRHTT
SCHEMBL8285161 0.83 PDE11A (0.47) PDE11AGAAPOLBHTTSMN1; SMN2
SCHEMBL8285163 0.82 POLB (0.50) PDE11AGAATSHRPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed